Range of Motion, Muscular Strength and Functionality of Patients Submitted to Total Hip Arthroplasty.

NCT03657680 | Completed

• 1 other identifier: THA patients evaluation
• Study Type: observational
• Target: 50
• Locations: 0 countries
• Sites: N/A

Brief Summary

Subjects in the late postoperative phase (5-8 months) of THA and control subjects without any signs or symptoms in the hip joint will be assessed for functionality (Harris Hip Score questionnaire and Timed Up and Go test), level of pain (visual analogue pain scale), hip range of motion and muscle isometric peak torque. This evaluation will be performed in order to compare functionality, level of pain, hip range of motion and peak torque between patients following total hip arthroplasty (THA) and asymptomatic controls.

Conditions

Hip Osteoarthritis

Outcome Measures

Primary Outcomes (1)

• Isometric Muscle Strenght - Biodex

  Hip muscle isometric strenght were assessed isometrically using a BiodexTM Multi Joint System 4 Pro isokinetic dynamometer (Biodex Medical Systems, New York, USA). Flexor, extensor, abductor and adductor muscle strength were measured.

  1 hour

Secondary Outcomes (4)

• Functionality - Timed Up and Go

  2 minutes

• Functionality - Harris Hip Score

  10 minutes

• Joint Range of Motion

  20 minutes

• Pain Intensity Evaluation

  5 minutes

Study Arms (2)

ATQ Group

Convenience sample of patients from Porto Alegre (RS, Brazil) who were experiencing unilateral hip osteoarthritis and were submitted to THA in referral hospitals at least five months previously to data collection. The volunteers were submitted to an evaluation of pain, range of motion, muscular strength and functional capacity.

Other: Evaluation

Control Group

The control group was composed of asymptomatic individuals from the community. The volunteers were submitted to an evaluation of pain, range of motion, muscular strength and functional capacity.

Other: Evaluation

Interventions

Evaluation OTHER

The volunteers were submitted to an evaluation of pain, range of motion, muscular strength and functional capacity.

ATQ Group; Control Group

Eligibility Criteria

• Age: 50 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients submited to unilateral total hip arthroplasty and healthy subjects, with no signs and symptons envolving hip joint.

You may qualify if:

• Age equal or superior to 50 years;
• have undergone a surgical procedure of unilateral total hip arthroplasty (cemented, non-cemented and hybrid prostheses) for at least 5 months and at most 18 months;
• referred by orthopedic physicians in the city of Porto Alegre or whose information (date of surgery, telephone contact, age and sex) were obtained through access to the computerized system in the physiotherapy sector of reference hospitals;
• who read and consent to the Informed Consent Form and understood the orientations necessary for the evaluation proposed in this study.

You may not qualify if:

• Performing a surgical procedure on other joints in the lower limbs;
• previous surgical procedures in the hip joint; osteoarticular diseases in lower limb joints;
• presence of signs or symptoms of contralateral hip osteoarthrosis;
• performed intra-articular injection of corticosteroids in the lower limbs during the last six months;
• cardiovascular diseases with the presence of disability, such as severe dyspnea and uncontrolled arterial hypertension;
• history of labyrinthitis;
• diabetes mellitus with signs of peripheral neuropathy and the presence of neurological diseases.

Sponsors & Collaborators

• Federal University of Health Science of Porto Alegre: lead

MeSH Terms

Conditions

Osteoarthritis, Hip

Condition Hierarchy (Ancestors)

Osteoarthritis; Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases

Study Officials

• Bruna M Lopes, Prof

  Federal University of Health Science of Porto Alegre

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Prof

Study Record Dates

• First Submitted: August 15, 2018
• First Posted: September 5, 2018
• Study Start: July 1, 2015
• Primary Completion: April 1, 2016
• Study Completion: April 1, 2016
• Last Updated: September 5, 2018

Record last verified: 2018-09

Data Sharing

• IPD Sharing: Will not share